Evofem Biosciences (EVFM) EBIT Margin (2020 - 2026)
Evofem Biosciences' EBIT Margin came in at -94.53% for Q2 2026, down 68.60 percentage points from -25.93% a year earlier but up 413.70 percentage points from the prior quarter.
Powered by 
Analysis
Evofem Biosciences (EVFM) EBIT Margin (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Evofem Biosciences reported EBIT Margin of -15.31%, up 9.98 percentage points year-over-year; for FY2025, it was 16.71%, up 56.35 percentage points from FY2024.
- EBIT Margin has increased in each of the last five years, with a five-year change of +23250.79 percentage points (FY2020 to FY2025).
- Going back by year, EBIT Margin was -39.64% in FY2024 (+58.32 pp), -97.96% in FY2023 (+401.67 pp), -499.64% in FY2022 (+1523.66 pp) and -2023.30% in FY2021 (+21210.78 pp).
- The five-year range for quarterly EBIT Margin is -6658.56% (Q4 2022) to 38.70% (Q1 2025).
- Year-over-year, EBIT Margin increased in six of the last eight quarters, with an average year-over-year change of -37.11 percentage points.
- The fastest year-over-year change in EBIT Margin over five years came in Q4 2021 (a gain of 20291.76 percentage points), and the weakest in Q4 2022 (a drop of 5610.44 percentage points).
- Business Quant data shows EVFM's EBIT Margin at -508.23% (Q1 2026), 34.99% (Q4 2025) and 19.20% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.37 Bn | 1,139.96 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 645.23 Bn | 565.09 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 502.25 Bn | 475.37 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 361.34 Bn | 315.71 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 302.82 Bn | 266.81 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 267.91 Bn | 241.60 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 242.39 Bn | 197.79 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 193.55 Bn | 167.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 172.05 Bn | 118.70 Bn | 10.94 Bn | 28.37% |
| 10 | Evofem Biosciences | 1.33 Mn | 1.33 Mn | 2.12 Mn | -94.53% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -94.53% |
| Mar 31, 2026 | -508.23% |
| Dec 31, 2025 | 34.99% |
| Sep 30, 2025 | 19.20% |
| Jun 30, 2025 | -25.93% |
| Mar 31, 2025 | 38.70% |
| Dec 31, 2024 | -14.12% |
| Sep 30, 2024 | -54.27% |
| Jun 30, 2024 | -33.39% |
| Mar 31, 2024 | -78.93% |
| Dec 31, 2023 | -69.85% |
| Sep 30, 2023 | -69.48% |
| Jun 30, 2023 | -298.45% |
| Mar 31, 2023 | -61.61% |
| Dec 31, 2022 | -6,658.56% |
| Sep 30, 2022 | -293.89% |
| Jun 30, 2022 | -404.69% |
| Mar 31, 2022 | -680.52% |
| Dec 31, 2021 | -1,048.12% |
| Sep 30, 2021 | -2,533.24% |
API Access
Evofem Biosciences EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();